Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
158 participants
INTERVENTIONAL
2003-06-30
2007-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of the Clinical Safety, Tolerability, and Efficacy of Zoledronic Acid Compared to an Oral Bisphosphonate
NCT00100555
Efficacy and Safety of Zoledronic Acid for the Treatment of Osteoporosis in Men
NCT00097825
The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients
NCT00114556
Switching Osteoporosis Patients Currently on Oral Bisphosphonate to Zoledronic Acid
NCT00097812
Bisphosphonate Therapy for Osteogenesis Imperfecta
NCT00159419
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zoledronic Acid
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* OI type I, III or IV
Exclusion
* Deformity or abnormality which would prevent spine bone density from being done
* Any surgical bone-lengthening procedure
* Any kidney diseases or abnormalities
* Low calcium or vitamin D levels in the blood
3 Months
17 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Novartis Pharmaceuticals
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UCLA - Division of Pediatric Nephrology
Los Angeles, California, United States
Alfred I. DuPont Hospital for Children
Wilmington, Delaware, United States
Intermountain Orthopedics
Boise, Idaho, United States
St. Jude Children's Research Hospital
Peoria, Illinois, United States
Children's Hospital
Omaha, Nebraska, United States
Children's Hospital Medical Center
Cincinnati, Ohio, United States
Children's Hospital
Columbus, Ohio, United States
Oregon Health Sciences University
Portland, Oregon, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Texas Children's Hosptial
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CZOL446H2202
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.